(Q38446727)

English

Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Tobias Banaschewski

3

object named as

Tobias Banaschewski

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ralf W. Dittmann

2

object named as

Ralf W Dittmann

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Peter M Wehmeier

1

object named as

Peter M Wehmeier

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ADHD - Attention Deficit and Hyperactivity Disorders

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

165-174

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

ADHD medication use, adherence, persistence and cost among Texas Medicaid children

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

In their own words: adolescent views on ADHD and their evolving role managing medication

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth.

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children.

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Stimulant adherence and academic performance in urban youth with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Attention-deficit/hyperactivity disorder and social dysfunctioning

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12402-014-0156-8

21 January 2018

Identifiers

10.1007/S12402-014-0156-8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Dimensions Publication ID

0 references

release_l7nas2cu2fainl4vqtn7sxpkwa

1 reference

https://api.fatcat.wiki/v0/release/l7nas2cu2fainl4vqtn7sxpkwa

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38446727&oldid=2201719098"